Yulia Green

机构：GlaxoSmithKline (Germany)

发表论文 22 篇 · 总被引 2336 次 · h-index 10

代表论文

• Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis (2020 · New England Journal of Medicine · 被引 1032)
• Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE study (2013 · European Respiratory Journal · 被引 389)
• Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study (2016 · The Lancet Respiratory Medicine · 被引 349)
• A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis (2021 · Kidney International · 被引 214)
• Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study (2019 · Arthritis & Rheumatology · 被引 141)
• Safety and Efficacy of Belimumab in Patients with Lupus Nephritis (2022 · Clinical Journal of the American Society of Nephrology · 被引 80)